Siemens Healthineers präsentiert das PET/CT-System Biograph Vision Quadra mit grösserem axialen Gesichtsfeld
Given the ever-changing healthcare landscape—one that is now even more fluid and volatile since the arrival of SARS-CoV-2—education and collaboration between nuclear medicine professionals and their colleagues are key to expanding and optimizing nuclear medicine’s utilization.
The treatment of musculoskeletal pain is a precise practice that requires accurate localization of possible pain generators. Given SPECT/CT's intrinsic anatomical and physiological imaging properties, it is an ideal choice in helping musculoskeletal medicine practitioners locate pain origins and develop effective treatment plans.
Hildegard Kaulen, PhD
Photography by Carsten Büll
Gallium-68 and fluorine-18-labeled PSMA ligands, imaged using PET/CT, are set to become a useful tool for primary staging and recurrence diagnosis in prostate cancer.
Photography by Alex Teuscher | Illustration by Clint Poy
SPECT/CT imaging is a ubiquitous tool that aides clinicians in making prompt diagnoses and developing personalized treatment strategies. With the addition of an automated tool that consistently produces reliable, quantitative measurements, providers explain how they are able to integrate quantification into their routine SPECT/CT protocols.
Univ.-Prof. Dr. Marcus Hacker
Our new column “Point of View” picks up trends and developments in healthcare. In this edition, Univ.-Prof. Dr. Marcus Hacker comments on the potential of AI in molecular imaging.
Photography by Ronald Patrick
At Siemens Healthineers’ recent Molecular Imaging World Summit, nuclear medicine and molecular imaging professionals were optimistic about the future as they examined trends, research, and technological advancements.The Summit fostered inspired discussion around opportunities for molecular imaging.
Colleen R. Smith, MBA
Photography by Alex Teuscher
SPECT/CT imaging is invaluable as we move toward precision medicine, and the significant addition of reliable quantitative measurements only enhances SPECT/CT’s opportunities. But as quantitative SPECT/CT looks to establish an active role in the next era of healthcare, the extent of its impact continues to be defined.
Kathryn J. McCullough
While imaging professionals work to contend with the progression of disease, they strive to improve diagnostic accuracy that supports personalized treatment for each patient, all while maintaining operational efficiency.
Joseph J. Diorio
Three nuclear medicine professionals reflect on the history of the field and how technology, over the course of 60 years, has helped shape nuclear medicine. Through their experiences, they offer insights into where they think the latest innovations will take nuclear medicine.
Photos: Nicole Webber
PETNET Solutions and Blue Earth Diagnostics expand Axumin availability to meet increasing clinical demands.
From its beginning nuclear medicine has constantly evolved, offering ever-better results and outcomes for patients. “But every so often along that journey there are quantum leaps,” says Iain Duncan, MD, co-founder of Garran Medical Imaging in Canberra, Australia. “xSPECT Bone is one of those leaps. No Question.”
Peter Bartenstein, MD
Data courtesy of Ludwig Maximillians University, Munich, Germany
A 69-year-old male with intestinal carcinoid tumor with multiple liver metastases, confirmed using 68Ga-DOTATOC PET/CT imaging, was referred for radionuclide therapy with 177Lu DOTATATE.
Samart Rajchadara, MD and Ananya Ruangma, PhD,
Data courtesy of Bangkok General Hospital, Bangkok, Thailand
A 38-year-old female presented with a left breast mass, which initially proved to be benign following an examination and aspiration biopsy. However, additional tests revealed papillary thyroid carcinoma coexisting with nodular goiter. Read more.